BWS Financial upgrades Biogen Idec Inc. (Nasdaq: BIIB) to Buy with a $70 price target.

The firm attributed the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE